ZeroStack（ZSTK）株式概要
ゼロスタック社は、子会社のファテボ社を通じて、ドイツで医薬品販売事業を行っている。 詳細
ZSTK Community Fair Values
Create NarrativeSee what 8 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
ZeroStack Corp. 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | US$4.29 |
| 52週高値 | US$47.00 |
| 52週安値 | US$3.72 |
| ベータ | 1.86 |
| 1ヶ月の変化 | -38.51% |
| 3ヶ月変化 | -48.38% |
| 1年変化 | -83.82% |
| 3年間の変化 | -97.71% |
| 5年間の変化 | -99.86% |
| IPOからの変化 | -99.89% |
最新ニュース
ナラティブの更新 • Feb 19
ZSTK: Forward Share Split Authorization Will Drive Future Upside Potential
Analysts have adjusted their price target on ZeroStack to $11.00. The change reflects updated views on discount rates and profit margin expectations, while fair value and future P/E assumptions remain steady.ナラティブの更新 • Feb 05
ZSTK: Forward Share Split Authorization Will Support Future Upside Potential
Analysts have raised their price target on ZeroStack to $11.00, citing a slightly higher profit margin outlook and a lower discount rate in their updated valuation work. What's in the News Flora Growth Corp.Recent updates
ナラティブの更新 • Feb 19
ZSTK: Forward Share Split Authorization Will Drive Future Upside Potential
Analysts have adjusted their price target on ZeroStack to $11.00. The change reflects updated views on discount rates and profit margin expectations, while fair value and future P/E assumptions remain steady.ナラティブの更新 • Feb 05
ZSTK: Forward Share Split Authorization Will Support Future Upside Potential
Analysts have raised their price target on ZeroStack to $11.00, citing a slightly higher profit margin outlook and a lower discount rate in their updated valuation work. What's in the News Flora Growth Corp.ナラティブの更新 • Jan 22
FLGC: Forward Share Split Authorization Will Support Future Upside Potential
Analysts have reduced their fair value estimate for Flora Growth from $20.50 to $11.00, citing updated assumptions that now reflect a steeper projected revenue decline of 24.87% along with a slightly lower discount rate and essentially unchanged profit margin and future P/E inputs. What's in the News Shareholders approved giving the board authority to change the company name to ZeroStack Corp.分析記事 • Jan 13
Flora Growth Corp. (NASDAQ:FLGC) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
To the annoyance of some shareholders, Flora Growth Corp. ( NASDAQ:FLGC ) shares are down a considerable 26% in the...ナラティブの更新 • Jan 07
FLGC: Forward Share Split And Preferred Share Authorization Will Drive Upside
Analysts now place their price target for Flora Growth at US$20.50, unchanged from the prior US$20.50. They cite only marginal tweaks to inputs, such as a slightly lower discount rate, while keeping revenue growth and profit margin expectations effectively stable.ナラティブの更新 • Dec 24
FLGC: Forward Share Split And Preferred Shares Will Support Upside Potential
Analysts have modestly raised their price target on Flora Growth, increasing the estimate by $0.00 to reflect a slightly higher perceived risk profile driven by an uptick in the discount rate, while keeping long term growth and profitability expectations essentially unchanged. What's in the News Shareholders approved giving the board authority to change the company name to ZeroStack Corp., create a new class of preferred shares, and implement a forward share split of between 2:1 and 10:1.ナラティブの更新 • Dec 10
FLGC: Forward Share Split And New Capital Raising Will Fuel Upside Potential
Analysts have modestly raised their price target on Flora Growth to $20.50, citing a slightly lower perceived risk reflected in a reduced discount rate, while maintaining stable expectations for revenue growth and profit margins. What's in the News Flora Growth has convened a special shareholders meeting for December 19, 2025 in Toronto to vote on corporate actions including capital structure and governance items (company filing).ナラティブの更新 • Nov 25
FLGC: Forward Share Split and Equity Offering Will Drive Renewed Momentum
Analysts have significantly lowered their price target for Flora Growth from $93.00 to $20.50. They cite revised expectations for revenue growth and a slightly reduced discount rate as key factors influencing this adjustment.分析記事 • Sep 09
Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 26% Yet They're Still Not Telling The Full Story
Flora Growth Corp. ( NASDAQ:FLGC ) shareholders are no doubt pleased to see that the share price has bounced 26% in the...ナラティブの更新 • Aug 19
US Cannabis And European Beverage Markets Will Create Opportunities
Flora Growth’s consensus Analyst Price Target was notably reduced from $156.00 to $93.00 due to continued gross margin pressure, underwhelming operational progress despite a strategic shift toward branded U.S. and European opportunities, and softer-than-expected recent results, although long-term confidence in management’s direction remains. Analyst Commentary Gross margin pressure negatively impacted Flora Growth's bottom line results this quarter.分析記事 • Jul 11
Investors Aren't Buying Flora Growth Corp.'s (NASDAQ:FLGC) Revenues
Flora Growth Corp.'s ( NASDAQ:FLGC ) price-to-sales (or "P/S") ratio of 0.3x might make it look like a buy right now...
新しいナラティブ • Apr 17
US Cannabis And European Beverage Markets Will Create Opportunities
Regulatory changes and strategic U.S. expansion could significantly enhance Flora's presence and revenue growth in the cannabis industry.分析記事 • Mar 27
Is Flora Growth (NASDAQ:FLGC) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...分析記事 • Jan 30
Flora Growth Corp. (NASDAQ:FLGC) Might Not Be As Mispriced As It Looks After Plunging 25%
To the annoyance of some shareholders, Flora Growth Corp. ( NASDAQ:FLGC ) shares are down a considerable 25% in the...分析記事 • Dec 01
Flora Growth Corp.'s (NASDAQ:FLGC) Price Is Right But Growth Is Lacking After Shares Rocket 28%
Flora Growth Corp. ( NASDAQ:FLGC ) shares have continued their recent momentum with a 28% gain in the last month alone...分析記事 • Nov 20
Health Check: How Prudently Does Flora Growth (NASDAQ:FLGC) Use Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...分析記事 • Sep 18
The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 26% But It Can Do More
Flora Growth Corp. ( NASDAQ:FLGC ) shareholders would be excited to see that the share price has had a great month...分析記事 • Aug 16
Newsflash: Flora Growth Corp. (NASDAQ:FLGC) Analysts Have Been Trimming Their Revenue Forecasts
Today is shaping up negative for Flora Growth Corp. ( NASDAQ:FLGC ) shareholders, with the analysts delivering a...分析記事 • May 22
Slammed 27% Flora Growth Corp. (NASDAQ:FLGC) Screens Well Here But There Might Be A Catch
The Flora Growth Corp. ( NASDAQ:FLGC ) share price has softened a substantial 27% over the previous 30 days, handing...分析記事 • Apr 04
Flora Growth Corp.'s (NASDAQ:FLGC) Shares Leap 143% Yet They're Still Not Telling The Full Story
Flora Growth Corp. ( NASDAQ:FLGC ) shareholders would be excited to see that the share price has had a great month...分析記事 • Feb 17
Investors Don't See Light At End Of Flora Growth Corp.'s (NASDAQ:FLGC) Tunnel And Push Stock Down 51%
The Flora Growth Corp. ( NASDAQ:FLGC ) share price has softened a substantial 51% over the previous 30 days, handing...分析記事 • Dec 22
The Market Lifts Flora Growth Corp. (NASDAQ:FLGC) Shares 41% But It Can Do More
Flora Growth Corp. ( NASDAQ:FLGC ) shares have had a really impressive month, gaining 41% after a shaky period...分析記事 • Apr 17
Investors Give Flora Growth Corp. (NASDAQ:FLGC) Shares A 28% Hiding
Flora Growth Corp. ( NASDAQ:FLGC ) shares have retraced a considerable 28% in the last month, reversing a fair amount...分析記事 • Dec 08
News Flash: Analysts Just Made A Meaningful Upgrade To Their Flora Growth Corp. (NASDAQ:FLGC) Forecasts
Flora Growth Corp. ( NASDAQ:FLGC ) shareholders will have a reason to smile today, with the analysts making substantial...株主還元
| ZSTK | US Healthcare | US 市場 | |
|---|---|---|---|
| 7D | 5.9% | -2.8% | -0.8% |
| 1Y | -83.8% | 14.6% | 27.1% |
業界別リターン: ZSTK過去 1 年間で14.6 % の収益を上げたUS Healthcare業界を下回りました。
リターン対市場: ZSTKは、過去 1 年間で27.1 % のリターンを上げたUS市場を下回りました。
価格変動
| ZSTK volatility | |
|---|---|
| ZSTK Average Weekly Movement | 17.7% |
| Healthcare Industry Average Movement | 7.5% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.2% |
安定した株価: ZSTKの株価は、 US市場と比較して過去 3 か月間で変動しています。
時間の経過による変動: ZSTKの weekly volatility ( 18% ) は過去 1 年間安定していますが、依然としてUSの株式の 75% よりも高くなっています。
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 2019 | 21 | Daniel Reis-Faria | zerostack.ai |
ZeroStack Corp.は、子会社のPhatebo GmbHを通じて、ドイツで医薬品流通事業に従事している。商業・卸売部門とデジタル資産部門を通じて事業を展開している。同社は、がん治療薬、注意欠陥・多動性障害、多発性硬化症、抗うつ薬など、様々な健康適応症を治療するための様々な医薬品や医療製品を販売している。また、0Gトークンの戦略的所有を通じてAIインフラの未来に投資する分散型AIトレジャリー企業としても事業を展開している。さらに、アーリーステージの企業への投資も行っている。同社は以前、Flora Growth Corp.として知られていたが、2026年1月にZeroStack Corp.に社名を変更した。ZeroStack Corp.は2019年に法人化され、カナダのトロントを拠点としている。
ZeroStack Corp. 基礎のまとめ
| ZSTK 基礎統計学 | |
|---|---|
| 時価総額 | US$10.21m |
| 収益（TTM） | -US$151.73m |
| 売上高(TTM) | US$36.08m |
0.3x
P/Sレシオ-0.1x
PER（株価収益率ZSTK は割高か？
公正価値と評価分析を参照収益と収入
| ZSTK 損益計算書（TTM） | |
|---|---|
| 収益 | US$36.08m |
| 売上原価 | US$31.82m |
| 売上総利益 | US$4.26m |
| その他の費用 | US$155.99m |
| 収益 | -US$151.73m |
直近の収益報告
Mar 31, 2026
次回決算日
該当なし
| 一株当たり利益（EPS） | -62.43 |
| グロス・マージン | 11.81% |
| 純利益率 | -420.49% |
| 有利子負債／自己資本比率 | 8.6% |
ZSTK の長期的なパフォーマンスは？
過去の実績と比較を見る企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/05/21 10:18 |
| 終値 | 2026/05/21 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
ZeroStack Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2
| アナリスト | 機関 |
|---|---|
| Rommel Dionisio | Aegis Capital Corporation |
| William Kirk | Roth Capital Partners |